Anticlotting Drug May Be Alternate to Warfarin
Study Shows Xarelto May Prevent Stroke and Blood Clots
WebMD News Archive
Warfarin Drawbacks continued...
Johnson & Johnson and Bayer HealthCare funded the new study.
This study was presented at a medical conference. The findings should be considered preliminary as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.